PRE 14A

PRELIMINARY PROXY STATEMENT

Company: TherapeuticsMD, Inc.
Filed: April 13, 2020
Period of Report: June 18, 2020
Accession Number: 0001387131-20-003861

View Document ↗ View on SEC.gov ↗